P
Piomic
Develops an innovative medical device for the treatment of hard-to-heal wounds
About Piomic
Piomic Medical is a startup specializing in advanced medical devices aimed at promoting the healing of chronic wounds. The company operates primarily in the healthcare sector, focusing on patients with chronic leg and foot ulcers, including those suffering from diabetic foot ulcers. Piomic's flagship product, the One Therapy System, is designed to enhance wound healing when used alongside standard treatments.
Piomic serves a diverse client base, including hospitals, clinics, and healthcare providers who treat patients with chronic wounds. The company operates in the global market, with a particular focus on regions where chronic wounds pose a significant healthcare challenge. Currently, Piomic is conducting clinical trials, such as the MAVERICKS trial, to evaluate the effectiveness of its therapy system in the U.S. and Canada. However, the One Therapy System has not yet received regulatory approval in these countries and is limited to investigational use.
Piomic's business model revolves around the development, certification, and sale of its medical devices. The company generates revenue by selling its One Therapy System to healthcare providers and institutions. Additionally, Piomic is actively seeking investors who align with its vision to expand its impact on global wound care.
The company has recently achieved significant milestones, including receiving MDR (Medical Device Regulation) certificates for its Class IIa and Class Is medical devices. This certification is crucial for ensuring the safety and effectiveness of medical devices in the European market.
Piomic is committed to data privacy and complies with the EU General Data Protection Regulation (GDPR) and Swiss data protection laws. The company ensures that personal data is stored, processed, accessed, and transferred securely and does not share personally identifiable information with third parties without explicit consent.
In summary, Piomic Medical is a forward-thinking company dedicated to improving chronic wound care through innovative medical devices, serving healthcare providers globally, and adhering to stringent data privacy standards.
Source: Dealroom company dataAt a glance
- Founded
- 2016
- Headquarters
- Zurich, Switzerland
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
European Commission
Series A4 investors entered at this stage
Swiss Diabetes Venture Fund
Nest Collective Foundation
Verve Ventures
ZKB - Zürcher Kantonalbank
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Piomic on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Piomic on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.